Menu

BeyondSPX has rebranded as EveryTicker. We now operate at everyticker.com, reflecting our coverage across nearly all U.S. tickers. BeyondSPX has rebranded as EveryTicker.

Price Performance Heatmap

5Y Price (Market Cap Weighted)

All Stocks (1091)

Company Market Cap Price
GKOS Glaukos Corporation
Glaukos directly manufactures ophthalmology devices, including iStent MIGS implants used in eye surgeries.
$7.17B
$124.75
+2.57%
HIMS Hims & Hers Health, Inc.
Laboratory testing & advisory services core to in-house lab capabilities.
$6.56B
$28.82
+6.78%
GRFS Grifols, S.A.
Gel Cards and reagent RBCs are consumables sold to diagnostics laboratories, fitting Medical Device Consumables.
$6.15B
$7.50
-1.57%
PLXS Plexus Corp.
Healthcare/Life Sciences end-market, with Plexus serving medical devices and related equipment through its engineering and manufacturing services.
$6.12B
$228.75
+2.63%
BLCO Bausch + Lomb Corporation
Ophthalmology Devices – direct manufacture and sale of eye-care surgical devices and related ophthalmic equipment.
$5.96B
$16.80
+1.27%
TFX Teleflex Incorporated
Teleflex is a global medical device company designing, manufacturing, and selling single-use medical devices across critical care, surgical, and interventional markets.
$5.82B
$131.54
+1.01%
AVTR Avantor, Inc.
Avantor provides Laboratory Testing & Advisory Services, aligning with outsourced testing and regulatory support offerings.
$5.81B
$8.52
+3.09%
ALKS Alkermes plc
Prefillable syringes as a packaging/administration technology for injectable products.
$5.70B
$34.52
+2.22%
LNTH Lantheus Holdings, Inc.
Liquid imaging agents (PET tracers and ultrasound contrast) place the company squarely in medical imaging as a core business.
$5.56B
$83.83
-0.11%
BRKR Bruker Corporation
Bruker directly manufactures diagnostic instrumentation and analytical equipment such as MALDI Biotyper and other diagnostic/imaging instruments.
$5.54B
$37.61
+3.01%
VNT Vontier Corporation
Repair Solutions includes diagnostic equipment launches for vehicle repair workflows.
$5.41B
$37.32
+2.33%
IPGP IPG Photonics Corporation
IPG markets medical laser systems including thulium lasers for urology, fitting Medical Devices & Biometrics.
$5.27B
$125.04
+3.59%
OSIS OSI Systems, Inc.
Patient Monitoring represents next-generation monitoring platforms and solutions within healthcare offerings.
$5.26B
$309.72
+2.87%
MIR Mirion Technologies, Inc.
Core business: Mirion designs and manufactures medical devices and biometric sensing equipment used in radiology, radiation therapy, and nuclear medicine.
$5.00B
$19.73
+2.36%
GNTX Gentex Corporation
Medical Devices & Biometrics covers EyeLock iris biometrics and eSight medical device initiatives tied to Gentex's diversification.
$4.95B
$22.62
+3.67%
STVN Stevanato Group S.p.A.
Directly manufactures Prefillable Syringes used for sterile biologic and small-molecule injections.
$4.70B
$15.59
+3.73%
SHC Sotera Health Company
Nelson Labs provides outsourced microbiological and analytical chemistry testing plus regulatory advisory services.
$4.63B
$16.31
+3.03%
NOVT Novanta Inc.
Medical Devices & Biometrics aligning with their focus on medical devices and biometric sensing technologies.
$4.61B
$128.85
+2.35%
NVST Envista Holdings Corp
Envista directly manufactures dental equipment, including implants and aligners, a core product line.
$4.58B
$27.84
+3.36%
AMRX Amneal Pharmaceuticals, Inc.
DHE autoinjector (Brekiya) approval signals involvement in auto-injector device delivery systems.
$4.37B
$13.90
+6.19%
MMSI Merit Medical Systems, Inc.
Vascular/interventional devices focus, including WRAPSODY endoprosthesis for dialysis access.
$4.21B
$70.91
+1.16%
IRTC iRhythm Technologies, Inc.
Direct product: iRhythm's patch-based patient monitoring device and associated software for continuous cardiac monitoring.
$4.04B
$125.38
+2.26%
TMDX TransMedics Group, Inc.
TransMedics' Organ Care System (OCS) is a proprietary medical device platform for organ preservation and monitoring.
$3.96B
$115.97
+6.28%
LIVN LivaNova PLC
Directly manufactures/distributes Neuromodulation Devices, including VNS Therapy and proximal hypoglossal nerve stimulation systems.
$3.67B
$67.12
+3.25%
UCTT Ultra Clean Holdings, Inc.
Provides laboratory testing and advisory services relevant to semiconductor manufacturing cleanliness and optimization.
$3.61B
$79.51
+4.02%
LQDA Liquidia Corporation
YUTREPIA includes a dry-powder inhaler device component, aligning with medical devices and equipment category.
$3.43B
$39.46
-4.69%
SXI Standex International Corporation
Specialty diagnostic/temperature-controlled healthcare equipment in the Scientific segment.
$3.37B
$278.84
+2.94%
TXG 10x Genomics, Inc.
TXG directly manufactures and sells diagnostic instrument platforms for single-cell and spatial biology workflows.
$3.30B
$26.11
+3.45%
ICUI ICU Medical, Inc.
Medical Device Consumables includes disposable items used with infusion therapy (Clave connectors, ChemoLock/ChemoClave CSTDs) and is a core revenue stream.
$3.21B
$129.91
+3.07%
ATS ATS Corporation
ATS-related offerings intersect with Medical Devices & Biometrics via automated production of regulated devices.
$3.17B
$32.75
+4.63%
ITGR Integer Holdings Corporation
The company manufactures medical devices and biometrics (sensors), aligning with the investable theme Medical Devices & Biometrics.
$3.16B
$90.24
+2.12%
CON Concentra Group Holdings Parent, Inc.
Laboratory testing & advisory services are part of the occupational health testing offerings and regulatory/compliance support seen in the business model.
$2.93B
$22.86
+2.37%
HAE Haemonetics Corporation
Haemonetics manufactures medical devices and biometrics for hospital blood management and plasma processing.
$2.88B
$61.61
+2.50%
ZLAB Zai Lab Limited
OPTUNE/Tumor Treating Fields program represents a medical device platform in cancer treatment.
$2.68B
$24.19
+2.94%
VCYT Veracyte, Inc.
The company offers MRD and other liquid biopsy tests, placing it in the liquid biopsy space.
$2.67B
$33.79
+2.30%
LMAT LeMaitre Vascular, Inc.
Directly produces vascular interventional devices (grafts, patches, shunts, catheters) used in vascular surgery.
$2.59B
$114.47
+2.53%
OGN Organon & Co.
Directly manufactures/markets medical devices (Nexplanon implant and Jada System) used in women's health and obstetric care.
$2.54B
$9.77
+4.66%
BBUC Brookfield Business Corporation
Operates private hospitals and related hospital services.
$2.54B
$34.77
+2.02%
← Previous
1 2 3 4 5 ... 11
Next →
Showing page 3 of 11 (1091 total stocks)

Loading company comparison...

Loading research report...

TXG 10x Genomics, Inc.

10x Genomics Unveils Atera, a Whole‑Transcriptome Spatial Biology Platform

Apr 19, 2026
GKOS Glaukos Corporation

Glaukos Secures Permanent Medicare J‑Code for Epioxa Keratoconus Therapy

Apr 16, 2026
OGN Organon & Co.

Organon’s VTAMA Cream Receives Strong Recommendation in 2026 AAD Pediatric Atopic Dermatitis Guidelines

Apr 15, 2026
MMSI Merit Medical Systems, Inc.

FDA Acknowledges Merit Medical’s Recall of 16F Dual‑Valved Splittable Sheath Introducer in Dialysis Catheters

Apr 14, 2026
OGN Organon & Co.

Sun Pharmaceutical Submits $12 Billion All‑Cash Offer for Organon & Co.

Apr 11, 2026
HIMS Hims & Hers Health, Inc.

Hims & Hers Reports Data Breach of Customer Support System, No Medical Records Compromised

Apr 03, 2026
MMSI Merit Medical Systems, Inc.

Merit Medical Systems Completes $140 Million Acquisition of View Point Medical

Apr 01, 2026
BBUC Brookfield Business Corporation

Brookfield Business Corporation Files 2025 Annual Report and Commences Trading of New Class A Shares

Mar 31, 2026
HAE Haemonetics Corporation

FDA Grants Expanded Labeling for Haemonetics’ VASCADE MVP XL Closure System

Mar 31, 2026
HIMS Hims & Hers Health, Inc.

Hims & Hers Expands Weight‑Loss Portfolio with Novo Nordisk GLP‑1 Products

Mar 27, 2026
MMSI Merit Medical Systems, Inc.

Merit Medical Secures Distribution Deal with Medtronic for ViaVerte Basivertebral Nerve Ablation System

Mar 25, 2026
TXG 10x Genomics, Inc.

10x Genomics, Bioptimus, and Broad Clinical Labs Announce STELA Spatial Atlas Initiative

Mar 25, 2026
BLCO Bausch + Lomb Corporation

Bausch + Lomb Announces 24‑Month Pivotal Trial Success for Implant‑Free ELIOS Glaucoma System

Mar 23, 2026